Durable virological and immunological treatment response as a result of treatment with nevirapine in combination with fixed-dose tenofovir plus emtricitabine: Interim analysis (24 months) of a non-interventional cohort study

S. Klauke, V. Cairns & J. Goldbach
Objectives: Nevirapine in combination with fixed dose tenofovir plus emtricitabine has been shown to be a highly active antiretroviral treatment regimen. The favourable long term tolerability, i.e. the metabolic profile, as well as the lack of CNS-effects of nevirapine may lead to the decision to start[for full text, please go to the a.m. URL]